Finally, given the suppressive role of CLDN7 during the process of EMT induced by TGFB1 and Musashi-2 [24, 27], it is a novel strategy to inhibit tumor progression by increasing CLDN7 expression. The gene discussed is MSI2; the disease is neoplasm.